Anti-PD-1 Therapy-Associated Perforating Colitis

Inhibition of immune checkpoint T cell regulatory molecules by using programmed cell death protein 1 (PD-1), or its ligand (PDL-1), and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) has been increasingly used to treat advanced malignancies. The immune-related adverse effects associated with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Celli, Romulo, Kluger, Harriet M., Zhang, Xuchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000840/
https://www.ncbi.nlm.nih.gov/pubmed/29955400
http://dx.doi.org/10.1155/2018/3406437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000840/
https://www.ncbi.nlm.nih.gov/pubmed/29955400
http://dx.doi.org/10.1155/2018/3406437

Ejemplares similares